Westlake Bio Unveils $320M Fund to Put Los Angeles on the Biotech Map
Xconomy
SEPTEMBER 5, 2018
Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. Westlake Village BioPartners is launching today with $350 million in committed capital. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light.
Let's personalize your content